(ENSG) The Ensign - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012
ENSG: Nursing Homes, Rehabilitation Services, Senior Living Facilities, Pharmacy Services
The Ensign Group, Inc. is a healthcare services company that operates a diverse range of facilities, including skilled nursing, senior living, and rehabilitative care centers. Through its Skilled Services segment, the company provides specialized care to patients with chronic conditions, prolonged illnesses, and elderly individuals, offering a broad spectrum of services such as on-site dialysis, ventilator care, cardiac and pulmonary management, as well as standard services like room and board, nutritional programs, and social activities. Additionally, the company's skilled nursing facilities offer rehabilitation therapy services, catering to the complex needs of patients requiring post-acute care.
The company's Standard Bearer segment, on the other hand, focuses on real estate investments, owning and leasing properties to skilled nursing and senior living operators. This strategic approach enables The Ensign Group to diversify its revenue streams and capitalize on the growing demand for healthcare services. Furthermore, the company provides a range of ancillary services, including digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory care, long-term care pharmacy, and patient transportation, which can be accessed by individuals in their homes or at long-term care facilities. The Ensign Group also offers mobile diagnostics, enhancing the accessibility and convenience of its healthcare services.
With operations spanning across 13 states, including Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin, The Ensign Group has established a significant presence in the US healthcare market. Founded in 1999 and headquartered in San Juan Capistrano, California, the company has evolved into a prominent player in the healthcare services sector, with a strong focus on delivering high-quality, patient-centered care. As a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ENSG, The Ensign Group is committed to creating long-term value for its shareholders while making a positive impact on the lives of its patients and communities.
Additional Sources for ENSG Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ENSG Stock Overview
Market Cap in USD | 7,676m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2007-11-09 |
ENSG Stock Ratings
Growth 5y | 93.8% |
Fundamental | 52.1% |
Dividend | 51.3% |
Rel. Strength Industry | 462 |
Analysts | 4.5/5 |
Fair Price Momentum | 147.61 USD |
Fair Price DCF | 87.19 USD |
ENSG Dividends
Dividend Yield 12m | 0.17% |
Yield on Cost 5y | 0.55% |
Annual Growth 5y | 3.68% |
Payout Consistency | 97.7% |
ENSG Growth Ratios
Growth Correlation 3m | -91% |
Growth Correlation 12m | 73.9% |
Growth Correlation 5y | 92.4% |
CAGR 5y | 25.80% |
CAGR/Mean DD 5y | 2.73 |
Sharpe Ratio 12m | 0.71 |
Alpha | -3.90 |
Beta | 0.84 |
Volatility | 22.04% |
Current Volume | 332.2k |
Average Volume 20d | 376k |
As of January 22, 2025, the stock is trading at USD 139.33 with a total of 332,169 shares traded.
Over the past week, the price has changed by +4.37%, over one month by +4.14%, over three months by -5.64% and over the past year by +18.83%.
Partly, yes. Based on ValueRay Fundamental Analyses, The Ensign (NASDAQ:ENSG) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 52.10 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENSG as of January 2025 is 147.61. This means that ENSG is currently overvalued and has a potential downside of 5.94%.
The Ensign has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy ENSG.
- Strong Buy: 4
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ENSG The Ensign will be worth about 163 in January 2026. The stock is currently trading at 139.33. This means that the stock has a potential upside of +16.96%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 169.5 | 21.7% |
Analysts Target Price | 112.2 | -19.5% |
ValueRay Target Price | 163 | 17% |